Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell differentiation antigen CD6 is a single-chain type I transmembrane glycoprotein predominantly expressed on mature human T lymphocytes, some B cells, medullary thymocytes, and at lower levels on other immune cells. The extracellular region contains three scavenger receptor cysteine-rich domains that mediate binding to its primary ligand ALCAM/CD166—a key event in cell adhesion and immunological synapse formation during antigen presentation. Functionally, CD6 acts as a costimulatory molecule essential for optimal activation and proliferation of T cells following engagement of the antigen-specific receptor complex. It also serves as a pattern recognition receptor capable of binding bacterial components such as lipopolysaccharide from Gram-negative bacteria and lipoteichoic acid from Gram-positive bacteria—triggering downstream signaling cascades including MAP kinase pathways that modulate inflammatory cytokine production. Genetic variants in *CD6* are associated with altered susceptibility to autoimmune diseases like multiple sclerosis.
For anti-CD6 antibodies like itolizumab, the mechanism involves blocking costimulatory signals required for full T-cell activation, thereby reducing pathogenic immune responses. It may also interfere with cell adhesion by disrupting the interaction between CD6 and its ligand ALCAM/CD166.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell differentiation antigen CD6 (CD6).